Trials / Completed
CompletedNCT04655144
Dexamethasone for Post Uterine Artery Embolization Pain
Intra-Arterial Dexamethasone for the Alleviation of Pain and Postembolization Syndrome Following Uterine Artery Embolization
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- Female
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to investigate if administration steroids (anti-inflammatory medication) via the uterine arteries during uterine fibroid embolization (A non surgical procedure for treating uterine fibroids by blocking their blood supply) can help reduce the pain, nausea, vomiting, and general feeling of weakness following the procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone | Dexamethasone delivered to the uterine arterial bed, prior to embolization. |
| DRUG | Saline | Saline delivered to the uterine arterial bed, prior to embolization. |
Timeline
- Start date
- 2021-01-25
- Primary completion
- 2024-12-04
- Completion
- 2024-12-04
- First posted
- 2020-12-07
- Last updated
- 2026-01-07
- Results posted
- 2025-09-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04655144. Inclusion in this directory is not an endorsement.